Ying Leng
yleng@simm.ac.cn
Chinese, English
Shanghai
University of Chinese Academy of Sciences
Medical School
  • 1996-09 to 1999-07 PhD: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
  • 2005-07 to Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Research Group Leader, Researcher
  • 2002-10 to 2004-01 - Karolinska Institute, Sweden - Postdoctoral Researcher
  • 2002-03 to 2005-06 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Research Group Leader, Associate Researcher
  • 1999-07 to 2002-03 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Assistant Researcher
Pharmacology of Diabetes and Metabolic Diseases
  • TGR5 agonist inhibits intestinal epithelial cell apoptosis via cAMP/PKA/c-FLIP/JNK signaling pathway and ameliorates dextran sulfate sodium-induced ulcerative colitis., ACTA PHARMACOLOGICA SINICA, 2023
  • Phenotypic screening-based drug discovery of furan-2-carboxylic acid derivatives for the amelioration of type 2 diabetes mellitus (T2DM), Eur J Med Chem, 2023
  • Coronarin A modulated hepatic glycogen synthesis and gluconeogenesis via inhibiting mTORC1/S6K1 signaling and ameliorated glucose homeostasis of diabetic mice, ACTA PHARMACOLOGICA SINICA, 2023
  • Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic Steatohepatitis, Journal of Medicinal Chemistry, 2023
  • Alisol B Alleviates Hepatocyte Lipid Accumulation and Lipotoxicity via Regulating RARα-PPARγ-CD36 Cascade and Attenuates Non-Alcoholic Steatohepatitis in Mice, NUTRIENTS, 2022
  • Development and structure-activity relationships of tanshinones as selective 11β-hydroxysteroid dehydrogenase 1 inhibitors, NATURAL PRODUCTS AND BIOPROSPECTING, 2022
  • Design, synthesis and structural-activity relationship studies of phanginin A derivatives for regulating SIK1-cAMP/CREB signaling to suppress hepatic gluconeogenesis, EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022
  • Design and exploration of gut-restricted bifunctional molecule with TGR5 agonistic and DPP4 inhibitory effects for treating ulcerative colitis, EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022
  • Phytochemicals from the Leaves of Cyclocarya paliurus and their 11 beta-HSD1 Enzyme Inhibitory Effects, CHEMISTRY & BIODIVERSITY, 2021
  • A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage, METABOLISM-CLINICAL AND EXPERIMENTAL, 2021
  • Design of G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) soft drugs with reduced gallbladder-filling effects, EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020
  • Discovery of Highly Polar beta-Homophenylalanine Derivatives as Nonsystemic Intestine-Targeted Dipeptidyl Peptidase IV Inhibitors, JOURNAL OF MEDICINAL CHEMISTRY, 2019
  • TGR5 agonist ameliorates insulin resistance in skeletal muscles and improves glucose homeostasis in diabetic mice, METABOLISM-CLINICAL AND EXPERIMENTAL, 2019
  • Linderane Suppresses Hepatic Gluconeogenesis by Inhibiting the cAMP/PKA/CREB Pathway Through Indirect Activation of PDE 3 via ERK/STAT3, FRONTIERS IN PHARMACOLOGY, 2018
  • Structural Elucidation and Bioinspired Total Syntheses of Ascorbylated Diterpenoid Hongkonoids A-D, JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018
  • Synthesis of selective 11β-HSD1 inhibitors based on dammarane scaffold, EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017
  • Design and synthesis of Atglistatin derivatives as adipose triglyceride lipase inhibitors, CHEMICAL BIOLOGY & DRUG DESIGN, 2017
  • Deheiculatins A-L, 20-oxygenated cembranoids from Macaranga deheiculata, PHYTOCHEMISTRY, 2017
  • Downregulation of lipin-1 induces insulin resistance by increasing intracellular ceramide accumulation in C2C12 myotubes, INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2017
  • Synthesis of selective 11 beta-HSD1 inhibitors based on dammarane scaffold, EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017
  • 16-nor Limonoids from Harrisonia perforata as promising selective 11 beta-HSD1 inhibitors, SCIENTIFIC REPORTS, 2016
  • Synthesis of hupehenols A, B, and E from protopanaxadiol, RSC ADVANCES, 2016
  • OL3, a novel low-absorbed TGR5 agonist with reduced side effects, lowered blood glucose via dual actions on TGR5 activation and DPP-4 inhibition, ACTA PHARMACOLOGICA SINICA, 2016
  • Analysis of diacylglycerols by ultra performance liquid chromatography-quadrupole time-of-flight mass spectrometry: Double bond location and isomers separation, ANALYTICA CHIMICA ACTA, 2016
  • Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effect, SCIENTIFIC REPORTS, 2016
  • Discovery and Structure-Activity Relationship Study of 4-Phenoxythiazol-5-carboxamides as Highly Potent TGR5 Agonists, CHEMICAL & PHARMACEUTICAL BULLETIN, 2016
  • Limonoids and Triterpenoids as 11 beta-HSD1 Inhibitors from Walsura robusta, JOURNAL OF NATURAL PRODUCTS, 2016
  • Design and Synthesis of Novel Arctigenin Analoguesfor the Amelioration of Metabolic Disorders, ACS MEDICINAL CHEMISTRY LETTERS, 2015
  • Yhhu4488, a novel GPR40 agonist, promotes GLP-1 secretion and exerts anti-diabetic effect in rodent models, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015
  • HC toxin (a HDAC inhibitor) enhances IRS1-Akt signalling and metabolism in mouse myotubes, JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2015
  • Hupehenols A-E, Selective 11 beta-Hydroxysteroid Dehydrogenase Type 1 (11 beta-HSD1) Inhibitors from Viburnum hupehense, JOURNAL OF NATURAL PRODUCTS, 2015
  • AICAR and Metformin Exert AMPK-dependent Effects on INS-1E Pancreatic β-cell Apoptosis via Differential Downstream Mechanisms, INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2015
  • Ricinodols A-G: new tetracyclic triterpenoids as 11 beta-HSD1 inhibitors from Ricinodendron heudelotii, RSC ADVANCES, 2015
  • Limonoids with 11 beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitory Activities from Dysoxylum mollissimum, JOURNAL OF NATURAL PRODUCTS, 2015
  • Yhhu981, a novel compound, stimulates fatty acid oxidation via the activation of AMPK and ameliorates lipid metabolism disorder in ob/ob mice, ACTA PHARMACOLOGICA SINICA, 2015
  • Dammarane-type triterpenoids as 11 beta-HSD1 inhibitors from Homonoia riparia, ORGANIC & BIOMOLECULAR CHEMISTRY, 2014
  • New rearranged limonoids from Walsura cochinchinensis, RSC ADVANCES, 2014
  • Lithocarpic acids O-S, five homo-cycloartane derivatives from the cupules of Lithocarpus polystachyus, BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014
  • Ingol-Type Diterpenes from Euphorbia antiquorum with Mouse 11 beta-Hydroxysteroid Dehydrogenase Type 1 Inhibition Activity, JOURNAL OF NATURAL PRODUCTS, 2014
  • Lithocarpic Acids A-N, 3,4-seco-Cycloartane Derivatives from the Cupules of Lithocarpus polystachyus, JOURNAL OF NATURAL PRODUCTS, 2014
  • SHR3824, a novel selective inhibitor of renal sodium glucose cotransporter 2, exhibits antidiabetic efficacy in rodent models, ACTA PHARMACOLOGICA SINICA, 2014
  • 4-Benzofuranyloxynicotinamide derivatives are novel potent and orally available TGR5 agonists, EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014
  • Further cycloartane and friedelane triterpenoids from the leaves of Caloncoba glauca, PHYTOCHEMISTRY LETTERS, 2014
  • Synthesis and biological evaluation of pyrrolidine-2-carbonitrile and 4-fluoropyrrolidine-2-carbonitrile derivatives as dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes, BIOORGANIC MEDICINAL CHEMISTRY, 2013
  • 11 beta-HSD1 Inhibitors from Walsura cochinchinensis
Diabetes Metabolic Diseases Pharmacology Insulin Resistance Glucose Metabolism Drug Discovery Therapeutics Endocrinology Signal Transduction Molecular Biology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.